Bloomberg
FDA Clears Pfizer Shot for Teens; U.S. Cases Slow: Virus Update
(Bloomberg) — The U.S. Food and Drug Administration approved the use of Pfizer-BioNTech vaccine for children aged 12 to 15. The number of new cases in U.S. rose last week at the slowest pace since the pandemic began, as more Americans are vaccinated and the nation recovers from a winter spike fueled by holiday travel.India’s capital of New Delhi extended its lockdown for another week as it battled a wave of infections…
Source link
